Literature DB >> 15659324

Role of macrophage migration inhibitory factor (MIF) in the skin.

Tadamichi Shimizu1.   

Abstract

Macrophage migration inhibitory factor (MIF) functions as a pleiotropic protein, participating in both inflammation and immune responses. MIF was originally discovered as a lymphokine involved in delayed type hypersensitivity and various macrophage functions, including phagocytosis, and tumor surveillance. Recently, MIF has been re-evaluated as a pro-inflammatory cytokine and identified as a pituitary-derived hormone, potentiating endotoxemia. MIF is ubiquitously expressed in various tissues, including the skin. Clinical evidence of increased MIF expression in inflammatory diseases supports this potential role of MIF in inflammation. In addition to its role in inflammation, MIF has been shown to exhibit growth-promoting activity, with anti-MIF antibodies effectively suppressing tumor growth and tumor-associated angiogenesis. This review presents the latest findings on the roles of MIF in the skin with regard to inflammation, the immune response, skin disease, tumorigenesis and cutaneous wound healing, and discusses its potential functions in various pathophysiological states.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15659324     DOI: 10.1016/j.jdermsci.2004.08.007

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  27 in total

1.  Serum level of macrophage migration inhibitory factor (MIF) in Egyptians with alopecia areata and its relation to the clinical severity of the disease.

Authors:  Doreen Nazeih Assaad Younan; Naglaa Agamia; Adel Elshafei; Nancy Ebeid
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

2.  UV-B radiation induces macrophage migration inhibitory factor-mediated melanogenesis through activation of protease-activated receptor-2 and stem cell factor in keratinocytes.

Authors:  Akiko Enomoto; Yoko Yoshihisa; Takako Yamakoshi; Mati Ur Rehman; Osamu Norisugi; Hiroshi Hara; Kenji Matsunaga; Teruhiko Makino; Jun Nishihira; Tadamichi Shimizu
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  Identification and expression of macrophage migration inhibitory factor in Sarcoptes scabiei.

Authors:  N M Cote; D C Jaworski; N B Wasala; M S Morgan; L G Arlian
Journal:  Exp Parasitol       Date:  2013-07-04       Impact factor: 2.011

4.  MIF antagonist (CPSI-1306) protects against UVB-induced squamous cell carcinoma.

Authors:  Priyadharsini Nagarajan; Kathleen L Tober; Judith A Riggenbach; Donna F Kusewitt; Amy M Lehman; Thais Sielecki; James Pruitt; Abhay R Satoskar; Tatiana M Oberyszyn
Journal:  Mol Cancer Res       Date:  2014-05-21       Impact factor: 5.852

5.  Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression.

Authors:  B Gesser; M K Rasmussen; L Raaby; C Rosada; C Johansen; R B Kjellerup; K Kragballe; L Iversen
Journal:  Inflamm Res       Date:  2011-02-22       Impact factor: 4.575

6.  Macrophage Migration Inhibitory Factor in Alopecia Areata and Vitiligo: A Case-Controlled Serological Study.

Authors:  Fatma Eldesouky; Al-Shimaa M Ibrahim; Samar M Sharaf
Journal:  J Clin Aesthet Dermatol       Date:  2020-10-01

7.  Tissue regeneration using macrophage migration inhibitory factor-impregnated gelatin microbeads in cutaneous wounds.

Authors:  Yunan Zhao; Tadamichi Shimizu; Jun Nishihira; Yoshikazu Koyama; Toshihiro Kushibiki; Ayumi Honda; Hirokazu Watanabe; Riichiro Abe; Yasuhiko Tabata; Hiroshi Shimizu
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

8.  Macrophage migration inhibitory factor promotes eosinophil accumulation and tissue remodeling in eosinophilic esophagitis.

Authors:  H S de Souza; C A Tortori; L Lintomen; R T Figueiredo; C Bernardazzi; L Leng; R Bucala; K Madi; F Buongusto; C C S Elia; M T L Castelo-Branco; M T Bozza
Journal:  Mucosal Immunol       Date:  2015-02-25       Impact factor: 7.313

9.  Expression of MIF and TNFA in psoriatic arthritis: relationship with Th1/Th2/Th17 cytokine profiles and clinical variables.

Authors:  L A Bautista-Herrera; U De la Cruz-Mosso; R Morales-Zambrano; G D Villanueva-Quintero; J Hernández-Bello; M G Ramírez-Dueñas; E Martínez-López; L M Brennan-Bourdon; C J Baños-Hernández; J F Muñoz-Valle
Journal:  Clin Exp Med       Date:  2017-09-30       Impact factor: 3.984

10.  Haplotype differences for copy number variants in the 22q11.23 region among human populations: a pigmentation-based model for selective pressure.

Authors:  Renato Polimanti; Sara Piacentini; Andrea Iorio; Flavio De Angelis; Andrey Kozlov; Andrea Novelletto; Maria Fuciarelli
Journal:  Eur J Hum Genet       Date:  2014-03-26       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.